Antibiograms of resistant Gram-negative bacteria from Scottish CF patients F.M. MacKenzie, S.V. Smith, K.E. Milne, K. Griffiths, J. Legge, I.M. Gould

Slides:

Advertisements

Similar presentations

Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis Giuseppe Valenza, Dennis Tappe, Doris.

Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Rapid emergence of a ceftazidime-resistant Burkholderia multivorans strain in a Cystic Fibrosis patient Joshua R. Stokell, Raad Z. Gharaibeh, Todd R.

Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery J. Abbott, J.S. Elborn, A.M. Georgiopoulos,

Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,

Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis Mohamed Zebouh, Caroline Thomas,

P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients Helle Krogh Johansen, Samuel.

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients Karen.

Use of high-dose ibuprofen in a pediatric cystic fibrosis center

R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J

Abaigeal D. Jackson, Christopher H. Goss Journal of Cystic Fibrosis

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF? Sarah P. Cohen, David M. Orenstein

Amoxicillin–clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings Gwen Duytschaever, Geert Huys,

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Transepithelial electrical measurements with the Ussing chamber

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Cirrhosis and other liver disease in cystic fibrosis

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin

Controlled clinical trials in cystic fibrosis — are we doing better?

D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn

The Journal of Cystic Fibrosis: Sunny perspectives

A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients Larissa Laine, John D. Perry, Jenner Lee,

A.H. Gifford Journal of Cystic Fibrosis

M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade

Demographics of glucose metabolism in cystic fibrosis

M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw

Cystic fibrosis related diabetes in an extremely young patient

Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas.

Direct comparison of in vitro susceptibility of wildtype clinical Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) to TOBI®

Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?

Cytokine gene polymorphisms and severity of CF lung disease

Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance P. Goncalves-Vidigal,

Nasal polyposis in lung transplant recipients with cystic fibrosis

Narelle S. Cox, Jennifer Follett, Karen O. McKay

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.

Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions Gerard McCaughey,

Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic Amanda L. Griffiths, Danielle F. Wurzel,

Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention H. White, K. Pollard, C. Etherington, I. Clifton,

Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire Joän M. Patterson, Melanie Wall, Jerica.

Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa Karen O. McKay, Peter J. Cooper, Peter P. van.

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis M.N. Hurley, A.H. Amin Ariff, C. Bertenshaw,

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis Giuseppe Valenza, Dennis Tappe, Doris.

Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation C. Etherington,

CFTR modulators and pregnancy: Our work has only just begun

Patient segregation and aggressive antibiotic eradication therapy can control methicillin- resistant Staphylococcus aureus at large cystic fibrosis centres

Ristan M. Greer, Helen M. Buntain, Peter J. Lewindon, Claire E

Beta-lactam allergy in adults with cystic fibrosis

N Dauletbaev, K Viel, R Buhl, T.O.F Wagner, J Bargon

Cheryl Cameron, Mark W. Lodes, William M. Gershan

CFTR, investigated with the two-electrode voltage-clamp technique: the importance of knowing the series resistance Georg Nagel Journal of Cystic Fibrosis

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L

A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity Henry J. Legere, Ross I. Palis, Tito Rodriguez.

Cystic fibrosis and pregnancy in the modern era: A case control study

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience C.R.

H. White, A.M. Morton, D.G. Peckham, S.P. Conway

Presentation transcript:

Antibiograms of resistant Gram-negative bacteria from Scottish CF patients F.M. MacKenzie, S.V. Smith, K.E. Milne, K. Griffiths, J. Legge, I.M. Gould Journal of Cystic Fibrosis Volume 3, Issue 3, Pages 151-157 (August 2004) DOI: 10.1016/j.jcf.2004.03.009

Fig. 1 (a) Percent isolates found susceptible to the β-lactams by NCCLS MIC testing. (b) Percent isolates found susceptible to the non-β-lactam antibiotics by NCCLS MIC testing. Journal of Cystic Fibrosis 2004 3, 151-157DOI: (10.1016/j.jcf.2004.03.009)